Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Na Lu

Showing results (531-540 of 875) with videos related to

Pageof 88
Sort By:
Inorganic Chemistry|August 26, 2025
Wavelength-Selective Photochromism in a Naphthalenediimide-Based Metal-Organic Framework: Mechanism, Ultrafast Response, and Inkless Printing ApplicationsYong-Sheng Shi, Jin-Fang Liu, Na-Na Lu, et al.
JAMA|March 13, 2019
Association of Tramadol With All-Cause Mortality Among Patients With OsteoarthritisChao Zeng, Maureen Dubreuil, Marc R LaRochelle, et al.
Journal of Healthcare Engineering|December 20, 2021
Diagnosis and Treatment Rules of Chronic Kidney Disease and Nursing Intervention Models of Related Mental Diseases Using Electronic Medical Records and Data MiningYanli Wang, Yueyao Sun, Na Lu, et al.
Plos One|March 13, 2014
LFG-500 inhibits the invasion of cancer cells via down-regulation of PI3K/AKT/NF-κB signaling pathwayChenglin Li, Fanni Li, Kai Zhao, et al.
Pharmacological Research|January 1, 2025
A comprehensive review on the plant sources, pharmacological activities and pharmacokinetic characteristics of SyringaresinolLei Zhang, Yuqing Tian, Lingling Zhang, et al.
Blood|March 15, 2013
Wogonoside induces cell cycle arrest and differentiation by affecting expression and subcellular localization of PLSCR1 in AML cellsYan Chen, Hui Hui, Hao Yang, et al.
BJU International|May 12, 2019
New-onset metabolic risk factors and the incidence of kidney stones: a prospective cohort studyHao Ping, Na Lu, Mingshuai Wang, et al.
Carcinogenesis|February 2, 2018
LYG-202 inhibits activation of endothelial cells and angiogenesis through CXCL12/CXCR7 pathway in breast cancerKai Zhao, Yuyuan Yao, Xuwei Luo, et al.
Journal of Neuroimmunology|April 16, 2023
Alemtuzumab treatment exemplifies discordant immune effects of blood and cerebrospinal fluid in multiple sclerosisLouisa Müller-Miny, Michael Heming, Tobias Lautwein, et al.
Biochemical and Biophysical Research Communications|July 24, 2007
Endostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR/Flk-1 of endothelial cellsYun Ling, Yong Yang, Na Lu, et al.
Pageof 88

Showing results (531-540 of 875) with videos related to

Sort By:
Pageof 88
Inorganic Chemistry|August 26, 2025
Wavelength-Selective Photochromism in a Naphthalenediimide-Based Metal-Organic Framework: Mechanism, Ultrafast Response, and Inkless Printing ApplicationsYong-Sheng Shi, Jin-Fang Liu, Na-Na Lu, et al.
JAMA|March 13, 2019
Association of Tramadol With All-Cause Mortality Among Patients With OsteoarthritisChao Zeng, Maureen Dubreuil, Marc R LaRochelle, et al.
Journal of Healthcare Engineering|December 20, 2021
Diagnosis and Treatment Rules of Chronic Kidney Disease and Nursing Intervention Models of Related Mental Diseases Using Electronic Medical Records and Data MiningYanli Wang, Yueyao Sun, Na Lu, et al.
Plos One|March 13, 2014
LFG-500 inhibits the invasion of cancer cells via down-regulation of PI3K/AKT/NF-κB signaling pathwayChenglin Li, Fanni Li, Kai Zhao, et al.
Pharmacological Research|January 1, 2025
A comprehensive review on the plant sources, pharmacological activities and pharmacokinetic characteristics of SyringaresinolLei Zhang, Yuqing Tian, Lingling Zhang, et al.
Blood|March 15, 2013
Wogonoside induces cell cycle arrest and differentiation by affecting expression and subcellular localization of PLSCR1 in AML cellsYan Chen, Hui Hui, Hao Yang, et al.
BJU International|May 12, 2019
New-onset metabolic risk factors and the incidence of kidney stones: a prospective cohort studyHao Ping, Na Lu, Mingshuai Wang, et al.
Carcinogenesis|February 2, 2018
LYG-202 inhibits activation of endothelial cells and angiogenesis through CXCL12/CXCR7 pathway in breast cancerKai Zhao, Yuyuan Yao, Xuwei Luo, et al.
Journal of Neuroimmunology|April 16, 2023
Alemtuzumab treatment exemplifies discordant immune effects of blood and cerebrospinal fluid in multiple sclerosisLouisa Müller-Miny, Michael Heming, Tobias Lautwein, et al.
Biochemical and Biophysical Research Communications|July 24, 2007
Endostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR/Flk-1 of endothelial cellsYun Ling, Yong Yang, Na Lu, et al.
Pageof 88